Organization
Center of Innovative Therapy
1 abstract
Abstract
ADDITIONAL ACR, EULAR, AND DAS28 RESPONSES AT 24 WEEKS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE NON-RESPONDERS TO COMBINED ETANERCEPT AND METHOTREXATE THERAPY AT 12 WEEKSOrg: Center of Innovative Therapy, Wyeth Pharmaceuticals, Amgen,